This suggests that the final approved dosing schedule (if and when retatrutide receives approval) may offer more flexibility than the Phase 2 protocol
The evaluation is free and nothing is charged until a prescription is written
Food and Drug Administration-approved medications
Ye Y, Tong F, Wang S, Jiang J, Gao J, Liu L, et al
Flashes of light, especially in your peripheral vision, may signal retinal traction or pulling
The FTC notes that the Commission has long been mindful of the potential anticompetitive effects of patent thickets, and that these patent thickets erected by incumbents can delay and frustrate the entry of new biosimilars and generic drugs, increasing prescription drug costs and limiting patients access to more affordable options. Overall, the FTC thinks the proposed rule will reduce[] gamesmanship by patent holders, as well as the number, size, and impact of patent thickets, promote competition, and that new market entrants will promote innovation and lower prices